PMID- 37790019 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231005 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 15 IP - 9 DP - 2023 Sep TI - Effect of Carbohydrate Loading in Diabetic Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled Trial. PG - e44570 LID - 10.7759/cureus.44570 [doi] LID - e44570 AB - INTRODUCTION: Investigations of preoperative oral carbohydrate (CHO) loading have primarily examined benefits among patients without diabetes. Preoperative CHO-rich beverages in general populations have resulted in reductions in insulin resistance after surgery, protein loss, metabolic derangements, and immune dysfunction. The aim of this study was to assess the effect of CHO loading in diabetic patients undergoing laparoscopic cholecystectomy. METHODS: Diabetic patients controlled on oral hypoglycemic agent were randomly divided into two groups: (1) Group T - this group will be given 50 g of maltodextrin before two hours of surgery; (2) Group C - this group will be kept nil per oral as per standard protocol. Blood sugar, serum insulin, serum cortisol, and insulin requirement were compared in both groups. RESULTS: Blood sugar levels of Group C were found to be significantly higher than that of Group T at six hours and 24 hours. In Group T, a rise in baseline serum insulin (8.94 +/- 3.43 mIU/l) was observed at 24 hours (13.23 +/- 5.71 mIU/l). A change of 4.29 +/- 3.00 mIU/l in serum insulin level was observed. The change in baseline serum insulin levels was 47.99%. In Group C too, a rise in baseline serum insulin (6.27 +/- 1.74 mIU/l) was observed at 24 hours (18.00 +/- 5.34 mIU/l). A change of 11.73 +/- 4.97 mIU/l in serum insulin level was observed. The change in baseline HOMA-IR (homeostatic model assessment for insulin resistance) levels in Group T was 53.66%. A rise (4.39 +/- 1.63) in baseline HOMA-IR of Group C (1.65 +/- 0.45) was observed at 24 hours (6.04 +/- 1.76). The change in baseline HOMA-IR levels in Group C was 266.06%. CONCLUSIONS: CHO loading is observed to be beneficial in diabetic patients undergoing laparoscopic cholecystectomy. No adverse effects or an increased risk of aspiration were observed in the intervention group during the study period. CI - Copyright (c) 2023, Yadav et al. FAU - Yadav, Kavita AU - Yadav K AD - Anesthesiology, King George's Medical University, Lucknow, IND. FAU - Prakash, Ravi AU - Prakash R AD - Anesthesiology, King George's Medical University, Lucknow, IND. FAU - Singh, Gyan Prakash AU - Singh GP AD - Anesthesiology, King George's Medical University, Lucknow, IND. FAU - Gautam, Shefali AU - Gautam S AD - Anesthesiology, King George's Medical University, Lucknow, IND. FAU - Arshad, Zia AU - Arshad Z AD - Anesthesiology, King George's Medical University, Lucknow, IND. FAU - Singh, Brijesh P AU - Singh BP AD - Anesthesiology, King George's Medical University, Lucknow, IND. LA - eng PT - Journal Article DEP - 20230902 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC10544875 OTO - NOTNLM OT - carbohydrate OT - carbohydrate loading OT - cortisol OT - diabetes mellitus OT - homa-ir OT - insulin OT - laparoscopic cholecystectomy OT - vas COIS- The authors have declared that no competing interests exist. EDAT- 2023/10/04 06:44 MHDA- 2023/10/04 06:45 PMCR- 2023/09/02 CRDT- 2023/10/04 03:57 PHST- 2023/09/02 00:00 [accepted] PHST- 2023/10/04 06:45 [medline] PHST- 2023/10/04 06:44 [pubmed] PHST- 2023/10/04 03:57 [entrez] PHST- 2023/09/02 00:00 [pmc-release] AID - 10.7759/cureus.44570 [doi] PST - epublish SO - Cureus. 2023 Sep 2;15(9):e44570. doi: 10.7759/cureus.44570. eCollection 2023 Sep.